SHINE announces first sales of n.c.a. Lu-177
SHINE announces first sales of its non-carrier-added lutetium-177
SHINE closes $80-million
SHINE closes $80-million Series C financing supported by Fidelity Management and Research Company LLC
SHINE Medical CEO Talks Europe Expansion, Future Phases of Company
In addition to creating a company that may soon supply two-thirds of the global demand for radioisotopes used in medical imaging, Wisconsin’s Greg Piefer is moving towards plans to create machinery that will produce clean energy and solve nuclear waste issues. At the...SHINE & IOCB deliver Lu-177 doses to GE
SHINE and IOCB Prague deliver patient dose quantities of lutetium-177 to GE Healthcare, advance therapeutic isotope toward commercialization
New ways to make molybdenum-99
A crucial short-lived isotope is in short supply
One fear raised by those who oppose Britain’s leaving the European Union without a deal is that the import of radioactive isotopes for medicine would be at risk. These short-lived substances might, people wo
Recent Comments